TickerFacts.

Vistagen Therapeutics, Inc. (VTGN): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2024-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2024-03-31
$528.0K2022-03-31: $02023-03-31: $528.0K2024-03-31: $0$0
2022-03-31 Capital Expenditures (USD) 2024-03-31
Period endedCapital ExpendituresChange YoYSource filing
2024-03-31$0-100.0%2024-06-11, From 2023-04-01
2023-03-31$528.0Kn/a2024-06-11, From 2022-04-01
2022-03-31$0n/a2023-06-28, From 2021-04-01